Obermatt
See Similar Stocks →

Schrödinger

NSQ:SDGR · US80810D1037
Health Care TechnologyMedium

360

14
Profit price76
Owner Earnings Yield1
Dividend Yield1
Price/Sales74
EV / Gross Profit39
Price/Book34
Return on Capital8
Cash Return on Capital10
Return on Equity16
EBIT Margin4
Gross Profitability37
Accruals63
Owner Earnings Margin8
Sales growth30
Profit growth46
Reinvestment81
Price momentum8
Debt load24
Refinancing17
Debt Payback1
Liquidity42
Analyst ratings30
Opinion Changes50
Price Target Upside73
Market mood59
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Schrödinger doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Technology
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded1990
Employees952
Websiteschrodinger.com
ISINUS80810D1037
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Artificial IntelligencePredictive AnalyticsMachine LearningImmunologySoftware DevelopmentOncologyNeurologyBiotechnologyEnterprise SoftwarePharmaceuticalSoftware

Description

Schrödinger, Inc. develops a physics-based computational platform that enables the discovery of novel molecules for drug development and materials applications. The company’s software platform is licensed by biopharmaceutical and industrial companie…

Analysis

Weak and unloved

Schrödinger, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is tepid; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value. Analysts lean positive.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
8
2023202420252026

All-time high

71

Jan 2024

All-time low

8

Jun 2026

Average rank

36

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
74
45
37
17
Price/Earnings
82
52
50
12
Price/Book
34
66
67
71
Dividend Yield
1
1
1
1
Value (overall)
54
47
39
37

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Schrödinger with its peers
Certara
NSQ:CERT
45
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Nurix Therapeutics
NMQ:NRIX
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zentalis Pharmaceuticals
NMQ:ZNTL
12
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Scholar Rock
NSQ:SRRK
67
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Inotiv
NAQ:NOTV
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →